"Vaccination Reduces Ebola Mortality in DRC Outbreak, Study Finds"

A new study has shown that the Ebola vaccine can significantly reduce the risk of death for people who were already infected with the virus, even if they received the vaccine after becoming ill. The research, based on data from the 2018-2020 Ebola Zaire outbreak in the Democratic Republic of the Congo, revealed that the risk of dying of Ebola was halved among vaccinated individuals. The study also indicated that the vaccine may activate the body's innate immune response and lower levels of virus in infected individuals, potentially aiding in the containment of Ebola outbreaks. Additionally, the findings suggest that the vaccine does not interfere with antibody treatments for Ebola, providing confidence in its use alongside therapeutic interventions.
- Ebola vaccine can save some who are already sick, per new study STAT
- Ebola Vaccine Study Reveals Survival Advantage | Latest Ebola News Medriva
- Ebola vaccine cut deaths in half during DRC outbreak, study shows University of Minnesota Twin Cities
- The Significant Impact of Merck Ervebo rVSV-ZEBOV-GP Vaccine in Reducing Ebola Mortality Medriva
- Vaccination halves mortality among people infected with Ebola Médecins Sans Frontières (MSF) International
Reading Insights
0
11
6 min
vs 7 min read
90%
1,224 → 118 words
Want the full story? Read the original article
Read on STAT